Pharmacuetical companies accused of refusing to invest in a cure

An Irish mum whose son suffers from a rare genetic disorder has accused pharmaceutical companies of refusing to invest in a cure.

Pharmacuetical companies accused of refusing to invest in a cure

An Irish mum whose son suffers from a rare genetic disorder has accused pharmaceutical companies of refusing to invest in a cure.

One-year-old Hagan Kavanagh has cystinosis which over time will crystallise his cells and destroy his organs.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited